Novavax and Endo climb after NVX-CoV2373 manufacturing services agreement Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Novavax (NVAX) and Endo (ENDP) up 5% and 7%, respectively, after Endo announced its subsidiary, Par Sterile Products, has entered into a non-exclusive agreement with Novavax to provide fill-finish manufacturing services at its plant in Rochester, Michigan for NVX-CoV2373 COVID-19 vaccine candidate
- DraftKings (DKNG) up 3% after
Argus analyst John Eade initiated coverage of the shares with a Buy rating and after Bloomberg reported that Apollo Global Management (APO) has approached U.K. gambling company William Hill (WIMHY) to discuss a potential takeover
- Colony Capital (CLNY) up 15% after entering into a definitive agreement to sell six of its hospitality portfolios to Highgate
in a transaction valued at $2.8B
- Outfront Media (OUT) up 4% after Citi analyst Jason Bazinet upgraded the stock to Buy from Neutral with a price target of $18, up from $17
- Altimmune (ALT) up 10% after D.E. Shaw disclosed a 5% stake in the company, which represents over 1.65M shares
DOWN AFTER EARNINGS -
ALSO LOWER -
- Fluor (FLR) down 2% after suspending 2020 guidance
- Net Element (NETE) down 7% after Mullen Technologies, which previously announced a definitive agreement to merge with the company in a stock-for-stock reverse merger, announced it will begin build-out of its pilot manufacturing facility and start taking pre-orders of its MX-05 fully electric SUV on October 1
Symbols:
APO WIMHY NVAX DKNG CLNY OUT ALT COST FLR NETE ENDP Keywords: Fly Intel, Wall Street, Top Stories, Stocks